Skip to content
Manufacturing, Medical Health Aged Care

Microban launches Ascera(TM): a patent-pending, cutting-edge antimicrobial technology inspired by nature

Microban International 2 mins read

Huntersville, NC Microban International is pleased to introduce its latest ground-breaking technology – Ascera™. This patent-pending, next generation antimicrobial technology uses an active ingredient inspired by nature*, and is designed for use in olefinic polymers and solvent-based coatings. Ascera is sustainable, metal free and less toxic than alternative technologies, and provides the lifelong antimicrobial product protection that Microban is known for around the world.

As the global leader in antimicrobial and odor-control technologies, Microban is committed to the development of solutions that support product sustainability by extending their useful lifetimes. Ascera exemplifies the company’s commitment to sustainability by offering lasting product protection while maintaining critical attributes, such as ease of incorporation, safe handling, and good chemical, thermal and UV stability. Ascera will perform for the product’s expected lifetime when applied according to Microban’s standards, effectively inhibiting the growth of odor-causing bacteria to prevent stains and premature aging of the finished product.

“Microban has always led the antimicrobial industry with technological innovations that contribute to product sustainability,” said Dr. Souvik Nandi, Vice President of R&D at Microban International. “In the past decade, regulatory and environmental groups have put increasing pressure on many of the antimicrobial chemistries that are currently used. As a result, Microban has invested significant resources in identifying naturally occurring solutions that are more sustainable and effective. We are very proud to roll out Ascera, which represents the culmination of many years of intensive research. This is the first of an exciting series of nature-inspired solutions that we will be launching in the next few years for different market segments and material types.”

“As the global leader in antimicrobial, odor-control and surface modification solutions, Microban is always standing at the forefront of the industry. As we work towards our vision of becoming the most trusted brand in ultimate cleanliness and product protection, we want the world to rely on Microban for best-in-class solutions.” Michael Ruby, President of Microban International, said. “Our R&D teams are laser-focused on developing a range of cutting-edge technologies that are nature inspired for the different market sectors we serve. Our partners look to us first for what is next. Ascera will help leading brands to create clean, odor-free and high value end-use products, which their customers will choose to support sustainability and live a clean and refreshing lifestyle."

Ascera is available to manufacturers in the U.S. and Asia, along with Microban’s support and expertise. Find out more at https://www.microban.com/antimicrobial-solutions/technologies/ascera and get in touch with a representative today!

*The Microban® technology used in this product is similar to acids found in nature and is used in multiple consumer product applications.


About us:

Company Website

https://www.microban.com/


Contact details:

Audrey Jestin at kdm communications limited,

St Neots, UK

+44 1480 405333

ideas@kdm-communications.com

More from this category

  • Medical Health Aged Care, Regional Country Services
  • 24/06/2024
  • 06:05
HCF

Innovative HCF funded project enhances heart failure treatment for regional Australians

MONDAY, 24 JUNE 2024: The HCF Research Foundation, Australia’s leading non-government funder of health services research is funding an innovative project led by Professor…

  • Contains:
  • Disability, Medical Health Aged Care
  • 24/06/2024
  • 06:00
MND Australia

Leaders in the motor neurone disease field arrive in Canberra today with a strong message: there’s no time to waste, more needs to be done to tackle MND.

Every day two Australians are diagnosed with motor neurone disease (MND) and two die from the disease. With no cure and an average life expectancy of just 27 months, we need more investment in MND to support people living with the disease and towards developing effective treatments. Today, MND Australia, the national peak body for MND, together with the Parliamentary Friends of MND, is hosting an event at Parliament House in Canberra to celebrate Global MND Day and honour 30 leaders in the MND field in recognition of MND Australia’s 30th anniversary. Lifetime achievement awards will be presented to people…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 24/06/2024
  • 05:00
ViiV Healthcare Australia

International artists and scientists raise funds to support women living with HIV in Asia and the Pacific

Monday 24 June 2024, Melbourne Australia: The National Association of People with HIV Australia (NAPWHA) and ViiV Healthcare Australia are proud to announce the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.